Dea No. 1680

• Neuroprotective Agents
• Central Nervous System Agents
• Anorexigenic Agents
• Stimulants
• ATC:N06BA07

• Dea No. 1680
• Modafinil [Usan:Inn]
• Modafinilo [Spanish]
• Modafinilum [Latin]
• Moderateafinil
• Modiodal
• Provigil

• No information avaliable

C₁₅H₁₅NO₂S

http://www.rxlist.com/cgi/generic2/modafinil.htm

Dea_No._1680 FDA

Dea_No._1680 MSDS

L. Lafon, U.S. pat. 4,927,855, (1990)

273.351 g/mol

164-166 ^oC

Slightly soluble

Solid

1.736

Tablet

To improve wakefulness in patients with excessive daytime sleepiness (EDS) associated with narcolepsy.

Modafinil is a stimulant drug marketed as a 'wakefulness promoting agent' and is one of the stimulants used in the treatment of narcolepsy. Narcolepsy is caused by dysfunction of a family of wakefulness-promoting and sleep-suppressing peptides, the orexins, whose neurons are activated by modafinil. The prexin neuron activation is associated with psychoactivation and euphoria. Modafinil is not indicated for complaints of lack of energy or fatigue; but it appears to be very helpful for some patients. Also, it has been used in the treatment of hypersomnia, a disorder in which patients lack the capacity for meaningful sleep and may require ten or more hours per day. Recent studies have have found that modafinil may help recovering cocaine addicts fight their addiction.

Rapid following oral administration.

No information avaliable

Humans and other mammals